Outset Medical Inc. (OM) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
RBC Capital Remains Positive on Outset Medical Inc. (OM)
February 14, 2023 9:35 AM ESTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $32.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "We caught up with the company twice since yesterday's release and believe the stock reaction is overdone because of the following reasons: (1) Q1 reflects typical seasonality for capital businesses, which represented 56% of the company's sales mix (consoles); in fact, we note that Q1 typically tends to be down sequentially for MedTech in general and... More
